Cell Therapy Market Size, Share, & Trends Analysis Report By Therapy Type (Autologous, Allogenic), By Therapeutic Area (Oncology, CVD, Dermatology), By Region, And Segment Forecasts, 2023 - 2030

Table of Content

Chapter 1 Executive Summary
1.1的市场Snapshot
Chapter 2 Research Methodology
2.1 Information Procurement
2.1.1 Purchased Database
2.1.2 GVR’s Internal Database
2.2 Data Analysis
2.3 Market Formulation & Validation
2.4 Approaches for Market Estimation
2.4.1 Approach 1: Commodity Flow & Bottom Up Approach
2.4.2 Approach 2: Top Down and Parent Market Analysis
Chapter 3 Market Variables, Trends, & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Rise in number of clinical studies pertaining to the development of cellular therapies
3.1.1.2 Rising adoption of regenerative medicine
3.1.1.3 Introduction of novel platforms and technologies
3.1.2 Market restraint analysis
3.1.2.1 Ethical concerns related to stem cell research
3.1.2.2 Clinical issues pertaining to development & implementation of cell therapy
3.1.2.2.1 Manufacturing issues
3.1.2.2.2 Genetic instability
3.1.2.2.3 Stem cell culture condition
3.1.2.2.4 Stem cell distribution after transplant
3.1.2.2.5 Immunological rejection
3.1.2.2.6 Challenges associated with allogenic mode of transplantation
3.2 Penetration & Growth Prospect Mapping For Therapy Type, 2022
3.3 Cell Therapy Market-Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis - Porter’s
Chapter 4 Cell Therapy Market Categorization: Therapy Type Estimates & Trend Analysis
4.1 Allogenic Cell Therapy
4.1.1 Global Allogenic Cell Therapy market, 2018 - 2030 (USD Billion)
4.1.2 Stem Cell Therapy
4.1.2.1 Global Allogenic Cell Therapy market for Stem Cell Therapy, 2018 - 2030 (USD Billion)
4.1.2.2 BM, Blood, & Umbilical Cord-derived Stem Cells
4.1.2.2.1 Global Allogenic Cell Therapy market for BM, Blood, & Umbilical Cord-derived Stem Cells, 2018 - 2030 (USD Billion)
4.1.2.3 Adipose Derived Cells
4.1.2.3.1 Global Allogenic Cell Therapy market for Adipose Derived Cells, 2018 - 2030 (USD Billion)
4.1.3 Non-Stem Cell Therapy
4.1.3.1 Global Allogenic Cell Therapy market for Non-Stem Cell Therapy, 2018 - 2030 (USD Billion)
4.1.3.2 T-Cell Therapy
4.1.3.2.1 Global Allogenic Cell Therapy market for T-Cell Therapy, 2018 - 2030 (USD Billion)
4.1.3.3. CAR-T Cell Therapy
4.1.3.3.1 Global Allogenic Cell Therapy market for CAR-T Cell Therapy, 2018 - 2030 (USD Billion)
4.1.3.4 T-Cell Receptor (TCR)
4.1.3.4.1 Global Allogenic Cell Therapy market for T-Cell Receptor (TCR), 2018 - 2030 (USD Billion)
4.1.3.5 Tumor Infiltrating Lymphocytes (TIL)
4.1.3.5.1 Global Allogenic Cell Therapy market for Tumor Infiltrating Lymphocytes (TIL), 2018 - 2030 (USD Billion)
4.1.3.6 Other Therapy
4.1.3.6.1 Global Allogenic Cell Therapy market for Other Therapy, 2018 - 2030 (USD Billion)
4.2 Autologus Cell Therapy
4.1.1 Global Autologus Cell Therapy market, 2018 - 2030 (USD Billion)
4.1.2 Stem Cell Therapy
4.1.2.1 Global Autologus Cell Therapy market for Stem Cell Therapy, 2018 - 2030 (USD Billion)
4.1.2.2 BM, Blood, & Umbilical Cord-derived Stem Cells
4.1.2.2.1 Global Autologus Cell Therapy market for BM, Blood, & Umbilical Cord-derived Stem Cells, 2018 - 2030 (USD Billion)
4.1.2.3 Adipose-Derived Cells
4.1.2.3.1 Global Autologus Cell Therapy market for Adipose Derived Cells, 2018 - 2030 (USD Billion)
4.1.3 Non-Stem Cell Therapy
4.1.3.1 Global Autologus Cell Therapy market for Non-Stem Cell Therapy, 2018 - 2030 (USD Billion)
4.1.3.2 T-Cell Therapy
4.1.3.2.1 Global Autologus Cell Therapy market for T-Cell Therapy, 2018 - 2030 (USD Billion)
4.1.3.3 CAR-T Cell Therapy
4.1.3.3.1 Global Autologus Cell Therapy market for CAR-T Cell Therapy, 2018 - 2030 (USD Billion)
4.1.3.4 T-Cell Receptor (TCR)
4.1.3.4.1 Global Autologus Cell Therapy market for T-Cell Receptor (TCR), 2018 - 2030 (USD Billion)
4.1.3.5 Tumor Infiltrating Lymphocytes (TIL)
4.1.3.5.1 Global Autologus Cell Therapy market for Tumor Infiltrating Lymphocytes (TIL), 2018 - 2030 (USD Billion)
4.1.3.6 Other Therapy
4.1.3.6.1 Global Autologus Cell Therapy market for Other Therapy, 2018 - 2030 (USD Billion)
Chapter 5 Cell Therapy Market Categorization: Therapeutic Area Estimates & Trend Analysis
5.1 Cell Therapy Market: Therapeutic Area Movement Analysis
5.2 Oncology
5.2.1 Global cell therapy market for oncology therapies, 2018 - 2030 (USD Million)
5.3 Cardiovascular Disease (CVD)
5.3.1全球细胞疗法cardiovascula市场r disease (CVD) therapies, 2018 - 2030 (USD Million)
5.4 Musculoskeletal Disorders
5.4.1 Global cell therapy market for musculoskeletal disorders therapies, 2018 - 2030 (USD Million)
5.5 Dermatology
5.5.1 Global cell therapy market for dermatology therapies, 2018 - 2030 (USD Million)
5.6 Others
5.6.1 Global cell therapy market for other therapies, 2018 - 2030 (USD Million)
Chapter 6 Cell Therapy Market Categorization: Regional Estimates & Trend Analysis
6.1 North America
6.1.1 SWOT Analysis
6.1.1.1 North America Cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.1.2 U.S.
6.1.2.1 Key country dynamics
6.1.2.2 Target disease prevalence
6.1.2.3 Competitive scenario
6.1.2.4 Regulatory framework
6.1.2.5 Reimbursement scenario
6.1.2.6 U.S. cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.1.3 Canada
6.1.3.1 Key country dynamics
6.1.3.2 Target disease prevalence
6.1.3.3 Competitive scenario
6.1.3.4 Regulatory framework
6.1.3.5 Reimbursement scenario
6.1.3.6 Canada cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.2 Europe
6.2.1 SWOT Analysis:
6.2.1.1 Europe cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.2.2 Germany
6.2.2.1 Key country dynamics
6.2.2.2 Target disease prevalence
6.2.2.3 Competitive scenario
6.2.2.4 Regulatory framework
6.2.2.5 Reimbursement scenario
6.2.2.6 Germany cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.2.3 U.K.
6.2.3.1 Key country dynamics
6.2.3.2 Target disease prevalence
6.2.3.3 Competitive scenario
6.2.3.4 Regulatory framework
6.2.3.5 Reimbursement scenario
6.2.3.6 U.K. cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.2.4 France
6.2.4.1 Key country dynamics
6.2.4.2 Target disease prevalence
6.2.4.3 Competitive scenario
6.2.4.4 Regulatory framework
6.2.4.5 Reimbursement scenario
6.2.4.6 France cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.2.5 Italy
6.2.5.1 Key country dynamics
6.2.5.2 Target disease prevalence
6.2.5.3 Competitive scenario
6.2.5.4 Regulatory framework
6.2.5.5 Reimbursement scenario
6.2.5.6 Italy cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.2.6 Spain
6.2.6.1 Key country dynamics
6.2.6.2 Target disease prevalence
6.2.6.3 Competitive scenario
6.2.6.4 Regulatory framework
6.2.6.5 Reimbursement scenario
6.2.6.6 Spain cell therapy market estimates and f.orecasts, 2018 - 2030 (USD million)
6.2.7 Denmark
6.2.7.1 Key country dynamics
6.2.7.2 Target disease prevalence
6.2.7.3 Competitive scenario
6.2.7.4监管框架
6.2.7.5 Reimbursement scenario
6.2.7.6 Denmark cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.2.8 Sweden
6.2.8.1 Key country dynamics
6.2.8.2 Target disease prevalence
6.2.8.3竞争场景
6.2.8.4 Regulatory framework
6.2.8.5 Reimbursement scenario
6.2.8.6 Sweden cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.2.9 Norway
6.2.9.1 Key country dynamics
6.2.9.2 Target disease prevalence
6.2.9.3竞争激烈的一场rio
6.2.9.4 Regulatory framework
6.2.9.5 Reimbursement scenario
6.2.9.6 Norway cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.2.10 Rest Of Europe cell therapy market Estimates And Forecasts, 2018 - 2030 (USD million)
6.3 Asia Pacific
6.3.1 SWOT Analysis:
6.3.1.1 Key Region Dynamics
6.3.1.2 Asia Pacific cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.3.2 Japan
6.3.2.1 Target disease prevalence
6.3.2.2 Competitive scenario
6.3.2.3 Regulatory framework
6.3.2.4 Reimbursement scenario
6.3.2.5 Japan cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.3.3 China
6.3.3.1 Target disease prevalence
6.3.3.2 Competitive scenario
6.3.3.3 Regulatory framework
6.3.3.4 Reimbursement scenario
6.3.3.5 China cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.3.4 India
6.3.4.1 Target disease prevalence
6.3.4.2 Competitive scenario
6.3.4.3 Regulatory framework
6.3.4.4 Reimbursement scenario
6.3.4.5 India cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.3.5 South Korea
6.3.5.1 Target disease prevalence
6.3.5.2 Competitive scenario
6.3.5.3 Regulatory framework
6.3.5.4 Reimbursement scenario
6.3.5.5 South Korea cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.3.6 Australia
6.3.6.1 Target disease prevalence
6.3.6.2 Competitive scenario
6.3.6.3 Regulatory framework
6.3.6.4 Reimbursement scenario
6.3.6.5 Austrlia cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.3.7 Thailand
6.3.7.1 Target disease prevalence
6.3.7.2 Competitive scenario
6.3.7.3 Regulatory framework
6.3.7.4 Reimbursement scenario
6.3.7.5 Thailand cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.3.8 Rest of Asia Pacific cell therapy market Estimates And Forecasts, 2018 - 2030 (USD million)
6.4 Latin America
6.4.1 SWOT Analysis
6.4.2 Key Regional Dynamics
6.4.2.1 Latin America cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.4.3 Brazil
6.4.3.1 Target disease prevalence
6.4.3.2 Competitive scenario
6.4.3.3 Regulatory framework
6.4.3.4 Reimbursement scenario
6.4.3.5 Brazil cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.4.4 Mexico
6.4.4.1 Target disease prevalence
6.4.4.2 Competitive scenario
6.4.4.3 Regulatory framework
6.4.4.4 Reimbursement scenario
6.4.4.5 Mexico cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.4.5 Argentina
6.4.5.1 Target disease prevalence
6.4.5.2 Competitive scenario
6.4.5.3 Regulatory framework
6.4.5.4 Reimbursement scenario
6.4.5.5 Argentina cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.4.6 Rest Of Latam cell therapy market Estimates And Forecasts, 2018 - 2030 (USD million)
6.5 Middle East & Africa (MEA)
6.5.1 SWOT Analysis
6.5.2 KEY regional DYNAMICS
6.5.2.1 Middle East & Africa cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.5.3 South AfricaA
6.5.3.1 Target disease prevalence
6.5.3.2 Competitive scenario
6.5.3.3 Regulatory framework
6.5.3.4 Reimbursement scenario
6.5.3.5 South Africa cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.5.4 Saudi Arabia
6.5.4.1 Target disease prevalence
6.5.4.2 Competitive scenario
6.5.4.3 Regulatory framework
6.5.4.4 Reimbursement scenario
6.5.4.5 Saudi Arabia cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.5.5 UAE
6.5.5.1 Target disease prevalence
6.5.5.2 Competitive scenario
6.5.5.3 Regulatory framework
6.5.5.4 Reimbursement scenario
6.5.5.5 UAE cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.5.6 Kuwait
6.5.6.1 Target disease prevalence
6.5.6.2 Competitive scenario
6.5.6.3 Regulatory framework
6.5.6.4 Reimbursement scenario
6.5.6.5 Kuwait cell therapy market estimates and forecasts, 2018 - 2030 (USD million)
6.5.7 Rest of MEA cell therapy market Estimates and Forecasts, 2018 - 2030 (USD million)
Chapter 7 Competitive Landscape
7.1 Strategy Framework
7.2 Company Profiles
7.2.1 Kolon TissueGene, Inc.
7.2.1.1 Company overview
7.2.1.2 Financial performance
7.2.1.3 Product benchmarking
7.2.1.4 Strategic initiatives
7.2.2 JCR Pharmaceuticals Co., Ltd.
7.2.2.1 Company overview
7.2.2.2 Financial performance
7.2.2.3 Product benchmarking
7.2.2.4 Strategic initiatives
7.2.3 MEDIPOST
7.2.3.1 Company overview
7.2.3.2 Financial performance
7.2.3.3 Product benchmarking
7.2.3.4 Strategic initiatives
7.2.4 Osiris Therapeutics, Inc.
7.2.4.1 Company overview
7.2.4.2 Financial performance
7.2.4.3 Product benchmarking
7.2.4.4 Strategic initiatives
7.2.5 Stemedica Cell Technologies, Inc.
7.2.5.1 Company overview
7.2.5.2 Financial performance
7.2.5.3 Product benchmarking
7.2.5.4 Strategic initiatives
7.2.6 Cells for Cells
7.2.6.1公司overview
7.2.6.2 Financial performance
7.2.6.3 Product benchmarking
7.2.6.4 Strategic initiatives
7.2.7 NuVasive, Inc
7.2.7.1 Company overview
7.2.7.2 Financial performance
7.2.7.3 Product benchmarking
7.2.7.4战略在itiatives
7.2.8 Fibrocell Science, Inc.
7.2.8.1 Company overview
7.2.8.2 Financial performance
7.2.8.3 Product benchmarking
7.2.8.4 Strategic initiatives
7.2.9 Vericel Corporation
7.2.9.1 Company overview
7.2.9.2 Financial performance
7.2.9.3 Product benchmarking
7.2.9.4 Strategic initiatives
7.2.10 PHARMICELL Co., Ltd
7.2.10.1 Company overview
7.2.10.2 Financial performance
7.2.10.3 Product benchmarking
7.2.10.4 Strategic initiatives
7.2.11 ANTEROGEN.CO有限公司
7.2.11.1 Company overview
7.2.11.2 Financial performance
7.2.11.3 Product benchmarking
7.2.11.4 Strategic initiatives
7.2.12 Celgene Corporation
7.2.12.1 Company overview
7.2.12.2 Financial performance
7.2.12.3产品基准测试
7.2.12.4 Strategic Initiatives

List of Tables

TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Global Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 4 Global Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 5 Global Cell Therapy Market by Region, 2018 - 2030 (USD Million)
TABLE 6 North America Cell Therapy Market by Country, 2018 - 2030 (USD Million)
TABLE 7 North America Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 8 North America Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 9 U.S. Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 10 U.S. Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 11 Canada Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 12 Canada Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 13 Europe Cell Therapy Market by Country, 2018 - 2030 (USD Million)
TABLE 14 Europe Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 15 Europe Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 16 Germany Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 17 Germany Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 18 U.K. Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 19 U.K. Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 20 France Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 21 France Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 22 Italy Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 23 Italy Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 24 Spain Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 25 Spain Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 26 Denmark Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 27 Denmark Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
表28日瑞典细胞Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 29 Sweden Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 30 Norway Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 31 Norway Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 32 Asia Pacific Cell Therapy Market by Country, 2018 - 2030 (USD Million)
TABLE 33 Asia Pacific Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 34 Asia Pacific Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 35 China Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 36 China Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 37 Japan Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 38 Japan Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 39 India Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 40 India Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 41 South Korea Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 42 South Korea Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 43 Australia Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 44 Australia Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 45 Thailand Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 46 Thailand Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 47 Latin America Cell Therapy Market by Country, 2018 - 2030 (USD Million)
TABLE 48 Latin America Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 49 Latin America Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 50 Brazil Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 51 Brazil Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 52 Mexico Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 53 Mexico Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 54 Argentina Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 55 Argentina Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 56 Colombia Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 57 Colombia Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 58 Chile Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 59 Chile Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 60 Middle East & Africa Cell Therapy Market by Country, 2018 - 2030 (USD Million)
TABLE 61 Middle East & Africa Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 62 Middle East & Africa Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 63 Saudi Arabia Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 64 Saudi Arabia Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 65 UAE Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 66 UAE Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)
TABLE 67 Kuwait Cell Therapy Market by Therapy Type, 2018 - 2030 (USD Million)
TABLE 68 Kuwait Cell Therapy Market by Therapeutic Area, 2018 - 2030 (USD Million)

List of Figures

FIG. 1 Information Procurement
FIG. 2 Primary Research Pattern
FIG. 3 Market Research Approaches
FIG. 4 Value Chain-Based Sizing & Forecasting
图5市场制定和验证
FIG. 6 Cell Therapy Market Segmentation
FIG. 7 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 8 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 9 Market Challenge Relevance Analysis (Current & Future Impact)
FIG. 10 Penetration & Growth Prospect Mapping
FIG. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
FIG. 12 Porter’s Five Forces Analysis
FIG. 13 Market Penetration Vs Growth Prospect Mapping, 2021
FIG. 14 Regional Marketplace: Key Takeaways
FIG. 15 Global Cell Therapy Market for Allogenic Stem Cell Therapies, 2018 - 2030 (USD Million)
FIG. 16 Global Cell Therapy Market for BM, Blood, & Umbilical Cord-derived Stem Cells, 2018 - 2030 (USD Million)
FIG. 17 Global Cell Therapy Market for Adipose-derived cells, 2018 - 2030 (USD Million)
FIG. 18 Global Cell Therapy Market for Others, 2018 - 2030 (USD Million)
FIG. 19 Global Cell Therapy Market for Allogenic Non-Stem Cell Therapies, 2018 - 2030 (USD Million)
FIG. 20 Global Cell Therapy Market for T-Cell Therapies, 2018 - 2030 (USD Million)
FIG. 21 Global Cell Therapy Market for CAR T Cell Therapy, 2018 - 2030 (USD Million)
FIG. 22 Global Cell Therapy Market for T Cell Receptor (TCR)-based, 2018 - 2030 (USD Million)
FIG. 23 Global Cell Therapy Market for Tumor Infiltrating Lymphocytes (TIL)-based, 2018 - 2030 (USD Million)
FIG. 24 Global Cell Therapy Market for Others, 2018 - 2030 (USD Million)
FIG. 25 Global Cell Therapy Market for Autologous Stem Cell Therapies, 2018 - 2030 (USD Million)
FIG. 26 Global Cell Therapy Market for Adipose-derived cells, 2018 - 2030 (USD Million)
FIG. 27 Global Cell Therapy Market for Others, 2018 - 2030 (USD Million)
FIG. 28 Global Cell Therapy Market for Autologous Non-Stem Cell Therapies, 2018 - 2030 (USD Million)
FIG. 29 Global Cell Therapy Market for T-Cell Therapies, 2018 - 2030 (USD Million)
FIG. 30 Global Cell Therapy Market for CAR T Cell Therapy, 2018 - 2030 (USD Million)
FIG. 31 Global Cell Therapy Market for T Cell Receptor (TCR)-based, 2018 - 2030 (USD Million)
FIG. 32 Global Cell Therapy Market for Tumor Infiltrating Lymphocytes (TIL)-based, 2018 - 2030 (USD Million)
FIG. 33 Global Cell Therapy Market for Others, 2018 - 2030 (USD Million)
FIG. 34 Global Cell Therapy Market for Oncology, 2018 - 2030 (USD Million)
FIG. 35 Global Cell Therapy Market for Cardiovascular Disease (CVD), 2018 - 2030 (USD Million)
FIG. 36 Global Cell Therapy Market for Musculoskeletal Disorders, 2018 - 2030 (USD Million)
FIG. 37 Global Cell Therapy Market for Dermatology, 2018 - 2030 (USD Million)
FIG. 38 Global Cell Therapy Market for Others, 2018 - 2030 (USD Million)
FIG. 39 Regional Outlook, 2021 & 2030
FIG. 40 North America Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 41 U.S. Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 42 Canada Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 43 Europe Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 44 Germany Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 45 U.K. Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 46 France Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 47 Italy Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 48 Spain Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 49 Denmark Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 50 Sweden Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 51 Norway Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 52 Asia Pacific Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 53 Japan Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 54 China Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 55 India Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 56 Australia Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 57 South Korea Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 58 Thailand Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 59 Latin America Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 60 Brazil Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 61 Mexico Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 62 Argentina Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 63 Chile Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 64 Colombia Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 65 Middle East and Africa Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 66 South Africa Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 67 Saudi Arabia Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 68 UAE Cell Therapy Market, 2018 - 2030 (USD Million)
FIG. 69 Kuwait Cell Therapy Market, 2018 - 2030 (USD Million)